Publicaciones (142) Publicaciones en las que ha participado algún/a investigador/a

2016

  1. Aislamiento pulmonar en pacientes con resecciones pulmonares previas: bloqueo lobular selectivo secuencial con bloqueador bronquial Fuji Uniblocker ®

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 63, Núm. 9, pp. 539-543

  2. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

    Europace, Vol. 18, Núm. 11, pp. 1609-1678

  3. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

    European Heart Journal, Vol. 37, Núm. 38

  4. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, Vol. 50, Núm. 5, pp. e1-e88

  5. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

    European Heart Journal, Vol. 37, Núm. 36, pp. 2768-2801

  6. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 36, Núm. 3, pp. 596-605

  7. A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia

    Schizophrenia Research, Vol. 170, Núm. 1, pp. 1-17

  8. ASS234, as a new multi-target directed propargylamine for Alzheimer's disease therapy

    Frontiers in Neuroscience, Vol. 10, Núm. JUN

  9. Activation of PPARβ/δ prevents hyperglycaemia-induced impairment of Kv7 channels and cAMP-mediated relaxation in rat coronary arteries

    Clinical Science, Vol. 130, Núm. 20, pp. 1823-1836

  10. Activity-dependent switch of gabaergic inhibition into glutamatergic excitation in astrocyte-neuron networks

    eLife, Vol. 5, Núm. DECEMBER2016

  11. Adverse drug reactions in neonates: A prospective study

    Archives of Disease in Childhood, Vol. 101, Núm. 4, pp. 371-376

  12. An update on atrial fibrillation in 2014: From pathophysiology to treatment

    International Journal of Cardiology, Vol. 203, pp. 22-29

  13. Apoptotic and necrotic basal forebrain cholinergic neuronal loss and dendritic spines alteration after acute and long-term chlorpyrifos exposure: Legal implications of the use of toxicogenomic profile as a biomarker of harmful effects induced under subclinical doses

    Medicina balear, Vol. 31, Núm. 1, pp. 24-34

  14. Application of the Integrated Safety Assessment methodology to safety margins. Dynamic Event Trees, Damage Domains and Risk Assessment

    Reliability Engineering and System Safety, Vol. 147, pp. 170-193

  15. Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: Risk assessment vs. Risk aversion

    European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 2, Núm. 3, pp. 200-205

  16. BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year

    Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151

  17. Bacterial translocation affects intracellular neuroinflammatory pathways in a depression-like model in rats

    Neuropharmacology, Vol. 103, pp. 122-133

  18. Biphasic effect of diabetes on neuronal nitric oxide release in rat mesenteric arteries

    PLoS ONE, Vol. 11, Núm. 6

  19. Brain-derived neurotrophic factor Val66met polymorphism and plasma levels in road traffic accident survivors

    Anxiety, Stress and Coping, Vol. 29, Núm. 6, pp. 616-629

  20. Cadmium-induced cell death of basal forebrain cholinergic neurons mediated by muscarinic M1 receptor blockade, increase in GSK-3β enzyme, β-amyloid and tau protein levels

    Archives of Toxicology, Vol. 90, Núm. 5, pp. 1081-1092